HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-T, non-B childhood acute lymphoblastic leukemia. Correlation between cytochemical markers and first complete remission.

Abstract
The positivity for four cytochemical reactions, acid phosphatase (AcP), alpha-naphtyl acid acetate esterase (ANAE), beta-glucuronidase (BG), and N-acetyl beta-glucosaminidase (NABG) was correlated to first remission duration in 120 children affected with non-T, non-B acute lymphoblastic leukemia (ALL). The percentages of patients remaining in complete remission at 72 months were always higher for children whose blasts lacked these enzymatic reactions; however, a statistical difference was found only between BG+ and BG- ALL. It also appears that more complete enzymatic patterns of leukemic cells are associated with a poorer prognosis. The percentage of patients still in their first remission was 89% for leukemias with no cytochemical markers, 59% when one reaction was present, but less than 39% when two or more enzymes were detected in the blasts. It is noteworthy that the blasts of patients with more severe prognosis demonstrated a simultaneous positivity for AcP-ANAE or BG-NABG cytochemical reactions. The possible usefulness of these cytochemical markers to detect subsets of patients with different prognostic significance among non-T, non-B ALL is discussed.
AuthorsG Basso, C Agostini, M G Cocito, A Pezzutto, R Destro, F Capuzzo, M V Gazzola, R Raimondi, L Zanesco, G Semenzato
JournalCancer (Cancer) Vol. 54 Issue 6 Pg. 981-5 (Sep 15 1984) ISSN: 0008-543X [Print] United States
PMID6590114 (Publication Type: Journal Article)
Chemical References
  • Hydrolases
  • Naphthol AS D Esterase
  • Acid Phosphatase
  • Glucuronidase
Topics
  • Acid Phosphatase (analysis)
  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Glucuronidase (analysis)
  • Humans
  • Hydrolases (analysis)
  • Infant
  • Leukemia, Lymphoid (enzymology, pathology)
  • Male
  • Naphthol AS D Esterase (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: